SEC Form 4 · accession 0002061393-26-000012

Medtronic plc · MDT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Accounting Officer

Period of report

Jul 31, 2026

Accepted (ET)

Aug 4, 2026 · 8:00 pm EDT

Rule 10b5-1 plan

box not checked

Issuer CIK

0001613103

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Ordinary Shares^F1,F2	Jul 31, 2026	F	212	$85.39	D	14,661	D
Ordinary Shares^F3	Aug 3, 2026	A	2,337	$0.00	A	16,998	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Performance Share Units^F4,F5,F6	—	Aug 3, 2026	A	2,337	A	—	—	Ordinary Shares	2,337	2,337	D
Stock Option (Right to Buy)^F7	$86.68	Aug 3, 2026	A	1,366	A	—	Aug 3, 2036	Ordinary Shares	1,366	1,366	D

F1Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.
F2Includes 136 shares acquired through dividend reinvestment since the last report filed by the reporting person.
F3Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
F4Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F5Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
F6The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 2,337 shares will be issued. If maximum performance metrics are achieved, 5,609 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F7These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.